David Cachia to DNA Modification Methylases
This is a "connection" page, showing publications David Cachia has written about DNA Modification Methylases.
Connection Strength
0.866
-
Das A, Henderson FC, Alshareef M, Porto GBF, Kanginakudru I, Infinger LK, Vandergrift WA, Lindhorst SM, Varma AK, Patel SJ, Cachia D. MGMT-inhibitor in combination with TGF-?RI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells. Clin Transl Oncol. 2021 Mar; 23(3):612-619.
Score: 0.643
-
Das A, Alshareef M, Porto GBF, Infinger LK, Vandergrift WA, Lindhorst SM, Varma AK, Patel SJ, Cachia D. Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment. J Neurol Sci. 2020 Nov 15; 418:117102.
Score: 0.162
-
Zhang S, Singh O, Dazelle K, Quezado M, Cimino PJ, Abdullaev Z, Wu J, Lucas CH, Schreck KC, Holdhoff M, Pytel P, Goodwill V, Macaulay R, McDonald W, Seidman R, Wood M, Bharani K, Neltner J, Richard H, Chang K, Szymanski L, Yip S, Mukherjee A, Lopes Abath Neto O, Sharma SJ, Green R, Brown D, Gubbiotti MA, Ballester LY, Eschbacher J, Smith-Cohn M, Gokden M, Vincentelli C, Yong W, Lee J, Mount C, Fulmer J, Sun M, Ligon K, Santi M, Pai EL, Yeaney G, Alexandrescu S, Raghavan R, Fernandes I, Reis GF, Mandel J, Caccamo D, Rao S, Butt OH, Dahiya S, Stone S, Conway K, Nasrallah MP, Fuller C, Toland A, Lukas RV, Cachia D, Uhlmann EJ, McCord M, Helgager J, Han K, Perry A, Perez S, Daoud E, BeDell D, Highfield H, Kobalka P, Nix JS, Nduom E, Neill S, Gilbert MR, Lakis N, Fonseca A, Shen C, Yoda R, Monterroza L, Cohen AL, Cathcart S, Al Amin M, Campian J, Aldape K. High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort. Neuro Oncol. 2026 Oct 01; 28(10):2435-2448.
Score: 0.062